The RUNX family in breast cancer: relationships with estrogen signaling.
about
Revealing the Complexity of Breast Cancer by Next Generation SequencingNovel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamicsThe role of genetics in estrogen responses: a critical piece of an intricate puzzle.RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programsRUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancerAssociations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.Genetic control of ductal morphology, estrogen-induced ductal growth, and gene expression in female mouse mammary gland.Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer.Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancerStratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts.RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.PVT1: a rising star among oncogenic long noncoding RNAs.S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applicationsRunx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasionIdentification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal.Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)Runx2 contributes to the regenerative potential of the mammary epithelium.Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations.Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer.Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate.Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells.RUNX1: A microRNA hub in normal and malignant hematopoiesis.Posttranslational modifications of RUNX1 as potential anticancer targets.The RUNX family: developmental regulators in cancer.Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.Aberrant AML1 gene expression in the diagnosis of childhood leukemias not characterized by AML1-involved cytogenetic abnormalities.Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
P2860
Q26777395-677A7BE7-FAA0-448D-9DAC-2BEEC6B6B1F2Q26777988-63C989C9-C915-4C79-8FB7-4E2AF4A94AD3Q28383242-A2C29712-C4ED-4071-9444-E44E3A776999Q33359083-36A4ACBB-B04D-49BD-9D1B-E92BD93A829CQ33555996-1F9B7E18-162C-406A-A952-011D8B4761E2Q33568421-495C42FB-7306-4F37-B7A9-BABE8072EF56Q33697210-31E1DADD-C4D4-43F2-9296-99949F7C50C8Q33732391-3C4BAA07-2E8A-4F37-8C29-A826226AAA44Q33812500-63C41443-A78B-4C1A-B6FC-04062465CA24Q33869600-DDEAEAC9-64E3-4D11-B994-5F6E32C0D648Q33901182-44CA7D31-7903-43FA-BE8C-1CD15D78947BQ33962806-C8F5E855-94E5-486E-A81A-B8662E69F665Q34038964-605B154E-5490-40F0-8D5B-6CD929CA60CDQ34258504-614743B0-AEF0-403C-93B9-DEB342EE7FCDQ35046149-DCECDAD1-CD22-4AA6-B809-E487B53D4C6CQ35240492-937F6F4E-731B-4B8B-ABF2-E679CB6CA8C8Q35287635-4E466521-72D8-452B-B90D-701053B1F538Q35337501-95215AEF-6A40-40CE-950E-828899BCC9E5Q35602148-8393CEA1-C954-478F-9DD4-F671565B5DE0Q35782827-DCCD3960-D170-43F8-8E60-A1D982225D45Q35806108-05674C01-D830-4AD3-B30F-76EBE40EAB2AQ35937737-2368C0F9-83D6-4BD5-B6F2-AC76C26549D3Q36140873-F3F1C29C-6C81-4B08-A731-FB31719BAF2EQ36189136-08520DAC-C836-4F20-9D41-FDCD2AD80F71Q36373503-9CAC61D6-55EA-4684-A180-20A52FE1AE7FQ36413997-C2FA7784-5667-4D9F-BB9B-120C47C6FB50Q36637143-D7E104AC-807E-4E0F-A6BE-1B0807D4042EQ36707069-880E2E8D-A5D3-48E0-AA3B-E98EC6D56C5DQ36813941-677A02EB-5904-4369-B604-A117570C2BB6Q37080584-9E985BF2-F2CF-48AD-ADD6-6EE687CA569FQ37167523-1C7EB920-4149-4DB0-BA57-2EFB2AEEC985Q37190507-CEC154A2-3A44-48D7-9E73-41BA31375C3EQ37663650-CF778994-89C0-44BD-BF24-0209B974FA0BQ37691008-57B7D3D7-E75C-47E2-A7C0-0121130A9892Q38076281-6103037D-4CF1-43D3-AABB-1F30D1A135A4Q38255068-5F0BC9C1-8D15-40F5-99F8-3F5A0FFAB7DBQ38319972-5B507A93-CD19-4270-A13E-012F0EDC6687Q38690842-45CF8080-0961-48F4-876D-A4E0CC0EF86CQ38710144-938E1BBB-AF43-44F0-9167-6AB6A0D90B7BQ38722836-AAD1A110-0C3F-4759-AD5E-54EC84E4547A
P2860
The RUNX family in breast cancer: relationships with estrogen signaling.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The RUNX family in breast cancer: relationships with estrogen signaling.
@en
type
label
The RUNX family in breast cancer: relationships with estrogen signaling.
@en
prefLabel
The RUNX family in breast cancer: relationships with estrogen signaling.
@en
P2860
P356
P1433
P1476
The RUNX family in breast cancer: relationships with estrogen signaling.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.328
P407
P577
2012-10-08T00:00:00Z
P5875
P6179
1038050216